3 ms·
Yes, as the trial size increases, i think the probability of a patient dying due to the challenge approaches 1. With regards to trials and deaths, I used to wo
by dekhn 5y ago
Yes, as the trial size increases, i think the probability of a patient dying due to the challenge approaches 1.
With regards to trials and deaths, I used to work in gene therapy and the entire field more or less stopped for 20 years when a single patient (https://en.wikipedia.org/wiki/Jesse_Gelsinger https://en.wikipedia.org/wiki/Jesse_Gelsinger) died in a trial. However, in most large trials, there will always be a few deaths that woudln't have occurred without the treatment (or challenge).